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St George’s Vascular Institute, London SW17 0RE, UKAngiosome-directed revascularisation of ischaemic limbs is
a source of growing debate. In contrast to other recent
systematic reviews,1 the current review2 suggests that,
when feasible, direct revascularisation (DR) using the
angiosome concept, may improve outcomes such as leg
salvage and wound healing.
There are many limitations of the evidence for this
novel concept, including small study numbers, predomi-
nantly retrospective data, use of historical controls, and
lack of angiographic data. The heterogeneity of data, pa-
tient characteristics, and lack of standardised deﬁnitions
are further confounders. One fundamental issue that
Professor Biancari does not address separately is the
concept of indirect revascularisation through collaterals
(IRc) and its effect on outcomes. The “angiosome” was
originally described as a three-dimensional network of
vessels, with a unit of tissue supplied by direct source
arteries, but reinforced by arterialearterial connections
between angiosomes.3 These collateral connections allow
compensatory blood ﬂow from a neighbouring angiosome
in the event that the direct artery to the given angiosome
is compromised. Therefore, the concept of IRc is important
to consider, given that outcomes may be similar to those
achieved with DR.4 However, the usefulness of IRc in a
population of patients with diabetes has potential limi-
tations. It follows that the obliteration of collaterals
typical of a patient with diabetes would likely render IRc
less useful than DR.
The angiosome concept was developed in healthy pa-
tients. Very little consideration has been given to the
distribution of angiosomes in patients with critical limb
ischaemia or diabetes. Recent evidence suggests that the
traditional angiosome model may not accurately predict
the distribution of blood ﬂow in an unselected group of
patients with critical ischaemia, whose pattern of perfu-
sion is distorted by abnormalities of the vascular bed,
development of collaterals (especially in patients with
diabetes) and atrophy of existing microvasculature.5
Therefore, the topographical location of an ulcer may
not actually correlate accurately with the source artery
supplying that area of tissue. With standard angiography,
it is impossible to ascertain the functional perfusion of aDOI of original article: http://dx.doi.org/10.1016/j.ejvs.2013.12.010
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ischaemia, the source artery may have been obliterated
and the major source of blood ﬂow may, in fact, arise from
a neighbouring angiosome. Therefore, direct targeting of
the angiosome, which correlates with the area of tissue
loss, may not be the appropriate strategy. A further area
for consideration is that many foot ulcers will span mul-
tiple angiosomes.
It is also difﬁcult to know the proportion of patients, in an
unselected population, in whom DR might be possibled-
most comparative series published so far have used his-
torical data and retrospectively applied criteria to
determine the approach that was ultimately used. It is
therefore difﬁcult to ascertain the feasibility of using the DR
approach in a prospective setting. Moreover, there is no
consensus as to the standard deﬁnitions used when
deﬁning and reporting angiosomes, making comparative
analyses difﬁcult.
Overall, we remain to be convinced that angiosome-
directed revascularisation offers signiﬁcant advantages
over the standard “best target artery approach”, although
we do acknowledge its potential role in treatment, partic-
ularly in patients with diabetes, where collateral circulation
is notably poor.
The key outstanding issues that remain to be deter-
mined are the ability to deﬁne angiosomes in patients with
CLI and to quantify the proportion of patients in whom it
may be technically possible to adopt angiosome-directed
revascularisation.
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